For a regulated molded part, the useful question is not whether a supplier can provide a generic certificate. It is whether the buyer can assemble a controlled evidence package for one identified part, resin route, intended use and market. The injection mold is one element of that package. It may establish repeatable cavities, gate locations and process capability, but it does not itself prove that a finished medical device or food-contact article meets every applicable requirement.
Start the RFQ with the product boundary and make the release decision visible. State the destination market, intended use, part revision, food or patient-contact boundary, sterilisation or cleaning exposure where relevant, resin and color direction, and who owns regulatory interpretation. Then require the molder to identify what it can evidence, what it cannot evidence, and which proposed changes need approval. This approach gives procurement a comparison basis without turning a quotation into an unsupported claim of certification or market clearance.
Treat regulatory documentation as a controlled, part-specific decision record. A resin data sheet, a mold trial sample or an ISO certificate may be useful inputs, but none is a universal approval of the finished product.
01
Define the regulatory claim, market and approval owner before requesting documents
A buyer should first separate a requirement from a recommendation. A requirement is a documented obligation from the applicable law, customer specification, quality system, risk file or contract. A recommendation is a practical way to reduce uncertainty, such as asking for a cavity map on a high-risk part. Put the requirement, source, owner and due date in the RFQ or quality agreement. Do not ask a molder to determine the legal status of a device or food-contact article from a CAD model alone.
For a medical project, identify whether the supplied item is a component, accessory or finished device; its intended market; contact and exposure assumptions; and the organisation that owns design, risk management and regulatory release. FDA states that the U.S. QMSR applies to finished-device manufacturers and incorporates ISO 13485:2016 by reference.[1] That context can inform supplier controls, but it does not make every mold shop a finished-device manufacturer or make an ISO certificate a product approval.
For a food-contact project, define the actual contact scenario: food category, contact temperature and duration, repeated-use or single-use condition, cleaning, microwave or heat treatment where applicable, and selling market. FDA explains that the regulatory status of a food-contact material depends on the status of each constituent that may migrate and on its authorised conditions of use.[2] In the EU, the framework requires food-contact materials to be made under good manufacturing practice and not transfer constituents in harmful quantities or unacceptably alter food.[3] A broad phrase such as ‘food grade’ does not supply these use conditions.
02
Request a controlled evidence pack, not a pile of unlinked certificates
Ask the supplier to submit a document index that links every record to the buyer part number, drawing revision, tool identification, resin manufacturer and exact grade, colorant or additive direction, and sample or production lot. The index should name the issuing organisation, issue date, revision, scope, document owner and any expiry or review date. Where the supplier is permitted to redact commercially sensitive formulation details, ask it to state the resulting evidence limitation and the route for confidential review rather than leaving a gap unexplained.
Typical supplier evidence may include the controlled drawing and specification; DFM and approved tool concept; tool number and cavity identification; material certificate or lot evidence when contracted; setup or processing record where required; first-article or agreed inspection report; nonconformance and deviation record; packaging or cleanliness evidence if specified; and change-notification history. Request only records that support a stated decision. A generic ‘certificate of conformity’ has limited value if it does not state the exact part, revision, basis of conformity, lot or batch, authorised signer and exceptions.
The buyer should also preserve its own inputs: approved resin route, intended-use statement, acceptance criteria, risk-based rationale for special controls, and approval signatures. This matters when a later question concerns a material substitute, cavity repair, different tool, revised drawing or changed contact condition. The complete record is a chain of evidence; a supplier document cannot fill in missing buyer-owned product requirements.
03
Compare medical and food-contact documentation by the decision it must support
The two applications can share basic manufacturing evidence, but they do not share a universal compliance pack. Medical documentation commonly focuses on defined design-transfer, traceability, acceptance and change-control needs set by the legal manufacturer or customer quality system. Food-contact documentation must connect material composition and processing to the intended food and use conditions. For EU plastic materials, Commission Regulation (EU) No 10/2011 provides for a written Declaration of Compliance and supporting documentation; the declaration must be renewed when substantial composition or production changes affect migration or when relevant new scientific data becomes available.[4]
Use the following matrix to compare quotations and to identify the buyer approval point before tool release or production release. The items are examples, not a substitute for a market-specific regulatory assessment.
| Decision area | Buyer must define | Supplier evidence to request | Approval or acceptance point |
|---|---|---|---|
| Part and market boundary | Part revision, destination market, intended use, regulatory owner and contractual scope | Document index confirming the part revision and declared supply scope | Buyer approves the evidence plan before tool release |
| Material route | Named resin grade, approved source policy, color/additive direction, permitted alternatives and applicable contact conditions | Grade identification, available supplier declarations, lot route if required, and written limitations | Buyer or delegated quality owner approves the material route; no generic ‘medical’ or ‘food grade’ substitute |
| Tool and production baseline | Tool ownership, cavity requirements, critical features, requested traceability and agreed process-record scope | Tool ID/cavity map, approved DFM or tool concept, sample identity and agreed inspection results | First article or sample decision is recorded against the controlled baseline |
| Food-contact evidence | Food type, time/temperature condition, repeated-use assumptions, target market and required declaration format | Applicable Declaration of Compliance or other authorised-use evidence, supporting-document availability and change notice | Regulatory owner confirms evidence fits the intended use before commercial release |
| Medical quality evidence | Customer quality clauses, cleanliness/packaging requirements, traceability depth, validation needs and record retention terms | Agreed inspection, lot or process records; deviation and change-control route; relevant quality-system scope if requested | Legal manufacturer or named delegate accepts the defined part and production evidence |
04
Set evidence gates from RFQ through routine supply
Use separate gates rather than a single vague approval. At quotation, approve the requirement list, responsibilities, document language and commercial assumptions. Before tool manufacture or tool release, approve the drawing revision, material direction, key tool assumptions, cavity identification approach and change-notice rules. At the first sample gate, compare the identified sample to the controlled drawing and agreed evidence plan, then record open items, deviations and their disposition. A signed sample does not automatically approve a different resin source, tool architecture, cavity count or end-use condition.
At production release, issue a short release record that identifies what is approved, what remains conditional, which lots or dates are covered, and the reaction to an out-of-specification result. Define whether the supplier must provide a certificate of conformance, inspection data, material-lot link, food-contact declaration, packaging record or no routine documents. The suitable frequency depends on the part risk, product requirements, resin, geometry, tool architecture, machine, market and contract terms; there is no universal evidence package or sampling level.
For a food-contact supply chain in the EU, traceability is an express framework requirement at all stages and operators need systems that identify upstream and downstream businesses and, where appropriate, supplied substances or products.[3] For any market, agree the practical traceability unit: production lot, molding run, cavity, resin lot, carton or another controlled identifier. It should be sufficient for the required containment and recall decision, not merely convenient to print.
05
Control changes, deviations and document retention as part of the purchase contract
Write a change matrix into the quality agreement or purchase specification. Changes that normally require prior written review can include a resin grade, manufacturer or formulation change; new colorant, regrind policy or additive; altered food-contact use conditions; cavity addition or removal; steel repair affecting a critical or contact surface; gate, cooling or ejection redesign; process changes outside an agreed validated or qualified range; subcontracting; packaging or cleanliness change; and a revised drawing. The needed evidence after a change should be proportionate to the stated risk and must be approved by the buyer’s designated authority.
Require the supplier to issue a deviation record before shipping a known departure from the controlled requirement. It should identify the affected part and lot, requirement, actual condition, evidence reviewed, containment, proposed disposition and expiry of any concession. A concession is a limited commercial and quality decision; it should not be described as a regulatory approval unless the responsible organisation has made that determination.
Agree retention period, language, electronic format, access method and transfer obligations if tooling moves or the supplier relationship ends. Retention is a contractual and market-dependent decision. The molder should preserve the records it has agreed to hold, while the product owner retains the controlled product file and market-access rationale. Reconfirm the packet after material, geometry, tool, process, machine, market or contract changes that could make the original evidence no longer representative.
Practical takeaway
Before you move
to the next review.
- Name the destination market, intended use, food or patient-contact boundary, part revision and the organisation that owns regulatory interpretation and release.
- Issue a buyer-controlled evidence matrix that distinguishes mandatory requirements from recommended risk controls and assigns an approver to each item.
- Request a revision-controlled supplier document index linking the part, tool or cavity, resin grade and source, sample or lot, evidence basis and any stated limitations.
- Approve separate quotation, tool-baseline, first-sample and routine-production gates; record deviations, conditions and expiry rather than using a blanket approval.
- Put material, tool, process, subcontracting, packaging and food-contact-use changes into a written notification and re-approval route with agreed record retention.
FAQ
Common questions
Does an ISO 13485 certificate prove that a molded component is compliant for a medical device?
No. A quality-system certificate can be relevant supplier evidence if its issuer, current status and scope are verified, but it does not by itself prove the suitability of a specific molded component, material route, intended use or finished device. The buyer should define the exact records, acceptance criteria and approval authority required for that part.
Can a resin data sheet or ‘food-grade’ statement replace a food-contact Declaration of Compliance?
Not necessarily. A data sheet may identify useful material properties, while a food-contact statement may have conditions, territory limits or source limitations. For an EU plastic article, the required evidence must be tied to the applicable rules and intended use; the buyer should verify the needed Declaration of Compliance and supporting-document route with the responsible regulatory owner.
What should be approved before an injection mold is released for a medical or food-contact project?
At minimum, approve the controlled part revision, material route, intended-use assumptions, critical features, traceability approach, requested supplier records, change rules and the first-sample acceptance plan. The exact package may also need cleanliness, packaging, migration, validation or functional evidence depending on the product and market.
When does a tooling or process change require new regulatory documentation?
Review it whenever the change could alter the evidence basis or the part’s conformity with the controlled requirements. Examples include resin or source changes, contact-surface repairs, new cavities, changed colorants or additives, altered contact conditions, and process changes outside the agreed scope. The designated buyer authority should determine whether notice, updated documents, new samples, testing or full re-approval is needed.
References
Source material
- [1] [1] U.S. Food and Drug Administration, Quality Management System Regulation (QMSR)
- [2] [2] U.S. Food and Drug Administration, Determining the Regulatory Status of Components of a Food Contact Material
- [3] [3] European Commission, Food Contact Materials—Legislation
- [4] [4] EUR-Lex, Commission Regulation (EU) No 10/2011 on plastic materials and articles intended to come into contact with food
This guide is general information for early procurement and engineering discussion. It does not replace product-specific DFM, qualification, validation, regulatory assessment or legal advice.